CN101204463A - Medicine for uterine cancer - Google Patents
Medicine for uterine cancer Download PDFInfo
- Publication number
- CN101204463A CN101204463A CNA2007101931655A CN200710193165A CN101204463A CN 101204463 A CN101204463 A CN 101204463A CN A2007101931655 A CNA2007101931655 A CN A2007101931655A CN 200710193165 A CN200710193165 A CN 200710193165A CN 101204463 A CN101204463 A CN 101204463A
- Authority
- CN
- China
- Prior art keywords
- medicine
- herba
- radix
- effect
- flavor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine used for treating uterine cancer and cancers. The medicine is made up of raw medicines as follows: 30g of portulaca grandiflora, 15g of night shade, 30g of selfheal, 30g of Gromwell Root, 20g of Indian strawberry, 50g of pepperweed seed, 5g of dodder, 30g of cornus, 20g of morinda officinalis how, 15g of tuckahoe, 50g of Japanese honeysuckle, 30g of dandelion and 15g of liquorice. The preparation method of the invention is as follows: firstly blending the raw materials according to the formula; secondly decocting the medicine in a pan which is filled with appropriate amounts of water; and thirdly filtering the medicine residue out of the medicines.
Description
One, technical field: the present invention relates to treat the medicine of cancer, especially a kind of medicine for the treatment of uterus carcinoma.
Two, background technology: uterus carcinoma belongs to a kind of cancer, patient's red tape of suffering from uterus carcinoma is more, pain is arranged, influence diet, health is become thin, and discrete have a heritability, the medicine of treatment uterus carcinoma is varied at present, Western medicine is arranged, Chinese medicine is arranged, can both receive effect in various degree, but all can not effect a radical cure uterus carcinoma.
Three, summary of the invention: the purpose of this invention is to provide a kind of medicine for the treatment of uterus carcinoma that can effect a radical cure uterus carcinoma, it has remedied the deficiency of other technology, the object of the present invention is achieved like this, it is made by following crude drug, Herba Portulacae Grandiflorae 30g, Herba Solani Nigri 15g, XIAKUQIU 30g, Radix Arnebiae (Radix Lithospermi) 30g, Herba Duchesneae Indicae 20g, the sub-50g of Roripa power, Semen Cuscutae 5g, Fructus Corni 30g, Radix Morindae Officinalis 20g, Poria 15g, Flos Lonicerae 50g, Herba Taraxaci 30g, Radix Glycyrrhizae 15g; Its preparation method is that the first step requires to prepare burden according to prescription; Second medicine of step after will preparing is put into to be converted an amount of water and decocts in the medicine pot; The 3rd step filtered, and leached medicinal residues and got final product.
Pharmacology analysis: Herba Portulacae Grandiflorae: meridian distribution of property and flavor, liver, lung meridian are returned in little hardship, cold; Effect, heat-clearing and toxic substances removing, invigorating blood circulation cancer.Herba Solani Nigri: meridian distribution of property and flavor, bitter, cold, return liver, stomach warp, effect, heat-clearing and toxic substances removing, promoting blood circulation and detumescence.XIAKUQIU: meridian distribution of property and flavor, bitter, hot, cold, return liver, gallbladder meridian; Effect, clearing away liver-fire, Disperse hepatic depression, blood pressure lowering.Radix Arnebiae (Radix Lithospermi): meridian distribution of property and flavor, sweet, cold, GUIXIN, Liver Channel; Effect, removing heat from blood and promoting blood circulation, detoxifcation rash; Herba Duchesneae Indicae: meridian distribution of property and flavor, sweet, bitter, cold, poisonous, return lung, liver, spleen channel; Effect, heat clearing away, removing heat from blood, detumescence, detoxifcation.Roripa power: meridian distribution of property and flavor, bitter, hot, Great Cold, return lung, urinary bladder channel; Effect, eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema.Semen Cuscutae: meridian distribution of property and flavor, hot, sweet, flat, return liver, kidney channel; Effect, the YANG invigorating tonifying YIN, the controlling nocturnal emission with astringent drugs reducing urination, antidiarrheal makes eye bright.Fructus Corni: meridian distribution of property and flavor, acid, tepor are returned liver, kidney channel; Effect, liver and kidney tonifying is restrained astringent or styptic treatment for spontaneous sweating.Radix Morindae Officinalis: meridian distribution of property and flavor, hot, sweet, tepor; Return kidney channel; Effect, reinforcing the kidney and supporting YANG, expelling wind and dampness.Poria: meridian distribution of property and flavor, sweet, light, flat, return spleen, the heart, kidney channel; Effect, promoting diuresis to eliminate damp pathogen, is calmed the nerves at spleen invigorating.Flos Lonicerae: meridian distribution of property and flavor, sweet, cold, return lung, stomach, large intestine channel, effect, heat-clearing and toxic substances removing.Herba Taraxaci: meridian distribution of property and flavor, sweet, be slightly cold, return liver, stomach warp; Effect, heat-clearing and toxic substances removing.
Treatment method: the medicinal liquid that leaches was finished off in the 1st day; The medicinal residues that leach were converted an amount of warm water in the 2nd day and decoct, after the decoction medicinal liquid that leaches is finished off; The medicinal residues that leach were converted an amount of warm water in the 3rd day and decoct, after the decoction medicinal liquid that leaches is finished off.
The patient source: general out patient service transfers 45 examples, and professional outpatient service transfers 35 examples.
Analysis of cases: among the 80 routine patients, 15 examples in 20-35 year, 45 examples in 36-50 year, 20 examples more than 51 years old.
Therapeutic outcome, cured person 72 examples account for 90% among the 80 routine patients, and other 8 examples belong to special circumstances, take the life that prolongs 8 months behind this medicine with regard to this 8 example.
Four, specific implementation method: the present invention is made by following crude drug, Herba Portulacae Grandiflorae 30g, Herba Solani Nigri 15g, XIAKUQIU 30g, Radix Arnebiae (Radix Lithospermi) 30g, Herba Duchesneae Indicae 20g, the sub-50g of Roripa power, Semen Cuscutae 5g, Fructus Corni 30g, Radix Morindae Officinalis 20g, Poria 15g, Flos Lonicerae 50g, Herba Taraxaci 30g, Radix Glycyrrhizae 15g; Its preparation method is that the first step requires to prepare burden according to prescription; Second medicine of step after will preparing is put into to be converted an amount of water and decocts in the medicine pot; The 3rd step filtered, and leached medicinal residues and got final product.
Claims (1)
1. medicine for the treatment of uterus carcinoma, it is characterized in that: it is made by following crude drug, Herba Portulacae Grandiflorae 30g, Herba Solani Nigri 15g, XIAKUQIU 30g, Radix Arnebiae (Radix Lithospermi) 30g, Herba Duchesneae Indicae 20g, the sub-50g of Roripa power, Semen Cuscutae 5g, Fructus Corni 30g, Radix Morindae Officinalis 20g, Poria 15g, Flos Lonicerae 50g, Herba Taraxaci 30g, Radix Glycyrrhizae 15g; Its preparation method is that the first step requires to prepare burden according to prescription; Second medicine of step after will preparing is put into to be converted an amount of water and decocts in the medicine pot; The 3rd step filtered, and leached medicinal residues and got final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101931655A CN101204463A (en) | 2007-12-17 | 2007-12-17 | Medicine for uterine cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101931655A CN101204463A (en) | 2007-12-17 | 2007-12-17 | Medicine for uterine cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101204463A true CN101204463A (en) | 2008-06-25 |
Family
ID=39565092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101931655A Pending CN101204463A (en) | 2007-12-17 | 2007-12-17 | Medicine for uterine cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101204463A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101706777B (en) * | 2009-11-10 | 2011-07-06 | 中国科学院计算技术研究所 | Method and system for extracting resequencing template in machine translation |
CN103977256A (en) * | 2014-05-23 | 2014-08-13 | 李绍华 | Medicine composition for treating cancer |
-
2007
- 2007-12-17 CN CNA2007101931655A patent/CN101204463A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101706777B (en) * | 2009-11-10 | 2011-07-06 | 中国科学院计算技术研究所 | Method and system for extracting resequencing template in machine translation |
CN103977256A (en) * | 2014-05-23 | 2014-08-13 | 李绍华 | Medicine composition for treating cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101564521B (en) | External plaster for treating hyperplasia of mammary glands | |
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN103356973A (en) | Antineoplastic traditional Chinese medicine | |
CN104288701A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
CN103877247A (en) | Medicine for treating bedsore and preparation method thereof | |
CN105535390A (en) | Traditional Chinese medicine decoction for treating coronary heart disease and preparation method of traditional Chinese medicine decoction | |
CN103735843A (en) | Medicine composition for treating diabetes | |
CN101269160B (en) | Chinese medicinal composition for treating trigeminal neuralgia | |
CN103263601A (en) | Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation | |
CN101204463A (en) | Medicine for uterine cancer | |
CN111491653A (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
CN100431595C (en) | Medicinal composition for treating qi stagnation and cold stasis stomach-ache and its preparing method and use | |
CN103127272A (en) | Chinese medicinal preparation for treating breast disease and preparation method thereof | |
CN104623381A (en) | Traditional-Chinese-medicine composition for treating skin disease caused by blood heat and liver depression | |
CN105535855A (en) | Traditional Chinese medicinal composition for treating hepatitis B and preparation method thereof | |
CN104857217A (en) | Traditional Chinese medicine composition for pregnant woman miscarriage prevention | |
CN104587126A (en) | Traditional Chinese medicine powder for treating stomach disease | |
CN105031505A (en) | Medicine for treating benign prostatic hyperplasia hypertrophy and preparation method thereof | |
CN104352899A (en) | Traditional Chinese medicinal preparation for treating chronic gastritis | |
CN103505579A (en) | Weight reducing plaster prescription | |
CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
CN100534473C (en) | Orally-administered traditional Chinese medicine composition for treating toothache | |
CN101147763A (en) | Orally-administered medicine for treating chloasma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20080625 |